Methylene blue

How Methylene Blue works

Methylene blue can accept and donate electrons, which lets it act as an alternative electron carrier in the mitochondrial energy chain. In lab and animal studies, low doses support mitochondrial respiration and reduce some kinds of oxidative stress. It also inhibits monoamine oxidase A, the enzyme that breaks down serotonin, which explains its dangerous interaction with serotonergic drugs.

Who it’s for, and who it isn’t

What’s included

• Clinician medication review focused on serotonergic drugs
• G6PD screening guidance (labs priced separately)
• Pharmaceutical-grade compounded capsules from a licensed U.S. pharmacy
• Follow-up on tolerance and any change in energy or focus

Possible side effects

• Blue or green urine, and sometimes blue-tinged stool or tongue
• Nausea or stomach upset
• Headache or dizziness
• Confusion or vision changes at higher exposures
• Falsely low readings on pulse oximeters
• Rare but serious: serotonin syndrome with interacting drugs, hemolysis in G6PD deficiency

This isn’t a complete list. Your clinician reviews risks, interactions and warnings with you before prescribing. In an emergency, call 911.

What the evidence says

Methylene blue is FDA-approved, as an intravenous product, to treat acquired methemoglobinemia, a blood disorder. Interest in low-dose use for energy, memory and aging comes mostly from cell and animal studies and a small number of short human studies. There are no long-term trials showing benefits for healthy adults, and any such use is off-label.

From hospital drug to wellness trend

Methylene blue has been used in medicine for more than a century. Today its approved role is narrow: an intravenous form treats methemoglobinemia, a condition in which blood cannot carry oxygen properly. Surgeons also use it as a dye.

Its newer popularity comes from research on mitochondria, the parts of cells that produce energy. Because methylene blue can shuttle electrons, researchers have explored whether small doses might help mitochondria work more efficiently, particularly in the brain. These are intriguing ideas, but they have not yet been confirmed by robust human trials.

The serotonin warning comes first

The FDA-approved product carries a boxed warning: serious or fatal serotonin syndrome can occur when methylene blue is combined with serotonergic drugs. FDA's reported cases involved SSRIs, SNRIs and clomipramine, and the risk with other psychiatric drugs, including MAOIs, bupropion, mirtazapine and trazodone, is unclear. The label also warns against combining it with opioids.

FDA has said it is not known whether low oral doses carry the same risk as the intravenous doses in those reports. Your clinician treats the interaction as real regardless. If you take any antidepressant, migraine triptan, certain pain medicines or other serotonergic drugs, methylene blue is very likely not an option.

• Agitation, confusion, fast heartbeat, fever, sweating, muscle twitching or stiffness: seek emergency care
• Never start a new prescription without telling the prescriber you take methylene blue

G6PD screening

People with G6PD deficiency, an inherited enzyme condition more common in people of African, Mediterranean, Middle Eastern and South Asian ancestry, can have their red blood cells break down when exposed to methylene blue. The approved product lists G6PD deficiency as a contraindication. Your clinician will ask about your history and may recommend a G6PD blood test before prescribing.

Why grade and source matter

Methylene blue is sold online in industrial, laboratory and aquarium grades that are not intended for people and may contain impurities such as heavy metals. A prescription product is compounded by a licensed U.S. pharmacy from pharmaceutical-grade material. Even so, compounded methylene blue is not FDA-approved, FDA has not reviewed it for safety, effectiveness or quality, and it is not interchangeable with the approved intravenous product.

How it compares with NAD+ and glutathione

Methylene blue, NAD+ and glutathione are often grouped together as cellular-energy or longevity treatments, but they work differently. NAD+ is a coenzyme the mitochondria already use; injections try to top up the supply. Glutathione is the body's main internal antioxidant. Methylene blue is a foreign compound that can step into the energy chain itself and also blocks an enzyme that breaks down serotonin.

That last point is why methylene blue has the most demanding screening of the three. None of them has strong evidence for improving energy or slowing aging in healthy adults, so the choice often comes down to your medication list, your tolerance for uncertainty and what your clinician thinks is worth a defined trial. Sleep, strength training and treating any underlying condition still come first.

What to expect day to day

Almost everyone notices blue or green urine, which is harmless but can be startling. It can also interfere with some urine dipstick tests and make pulse oximeters read falsely low, so tell any care team you take it. Some people report sharper focus or more energy; others notice nothing. Nausea and headache are possible.

What your clinician monitors

Before you start, your clinician reviews every medication and supplement you take, including over-the-counter products such as dextromethorphan and St. John's wort. Follow-up covers side effects, any new prescriptions and whether you are noticing a meaningful benefit. If not, stopping after a defined trial is reasonable.

Methylene blue costs from $149 a month, or $299 for 3 months ($100 a month), with no membership fee. Labs, including any G6PD test, are billed separately, and your price is confirmed at the eligibility review.

Go deeper on Methylene Blue